[go: up one dir, main page]

IS2691B - Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð - Google Patents

Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð

Info

Publication number
IS2691B
IS2691B IS7065A IS7065A IS2691B IS 2691 B IS2691 B IS 2691B IS 7065 A IS7065 A IS 7065A IS 7065 A IS7065 A IS 7065A IS 2691 B IS2691 B IS 2691B
Authority
IS
Iceland
Prior art keywords
dose
contraceptives
emergency contraception
contraception
emergency
Prior art date
Application number
IS7065A
Other languages
English (en)
Other versions
IS7065A (is
Inventor
Paul F A Van Look
Illesne Balogh
Katalin Komandi
Laszlo Nemes
Zsolt Szabo
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of IS7065A publication Critical patent/IS7065A/is
Publication of IS2691B publication Critical patent/IS2691B/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IS7065A 2001-11-27 2003-12-05 Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð IS2691B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel
PCT/HU2002/000129 WO2003045397A1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception

Publications (2)

Publication Number Publication Date
IS7065A IS7065A (is) 2003-12-05
IS2691B true IS2691B (is) 2010-10-15

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7065A IS2691B (is) 2001-11-27 2003-12-05 Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð

Country Status (33)

Country Link
US (1) US20050288264A2 (is)
EP (1) EP1448207B1 (is)
JP (1) JP2005516904A (is)
KR (1) KR100908161B1 (is)
CN (1) CN1551774A (is)
AP (1) AP1849A (is)
AT (1) ATE293978T1 (is)
AU (1) AU2002347401A1 (is)
BR (1) BR0210595A (is)
CA (1) CA2450359C (is)
DE (1) DE60203929T2 (is)
DK (1) DK1448207T3 (is)
EA (1) EA006545B1 (is)
EC (1) ECSP045171A (is)
ES (1) ES2239727T3 (is)
GE (1) GEP20063882B (is)
HR (1) HRP20040584B1 (is)
HU (1) HU227198B1 (is)
IL (1) IL159394A0 (is)
IS (1) IS2691B (is)
MA (1) MA27076A1 (is)
MX (1) MXPA04005104A (is)
NO (1) NO333984B1 (is)
NZ (1) NZ530056A (is)
OA (1) OA12730A (is)
PL (1) PL206010B1 (is)
PT (1) PT1448207E (is)
RS (1) RS50768B (is)
SI (1) SI1448207T1 (is)
TN (1) TNSN04048A1 (is)
UA (1) UA79942C2 (is)
WO (1) WO2003045397A1 (is)
ZA (1) ZA200404114B (is)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
CA2710293A1 (en) * 2007-12-20 2009-07-02 Teva Women's Health, Inc. Dosage regimens and pharmaceutical compositions and packages for emergency contraception
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
CA2745541C (en) 2008-12-12 2016-11-08 Laboratoire Hra-Pharma A method for contraception
DK2419108T3 (en) 2009-04-14 2016-12-05 Hra Pharma Lab A method for on-demand control of conception,
JP5801801B2 (ja) 2009-06-23 2015-10-28 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 緊急避妊のための医薬組成物及び処置方法
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
WO2012164095A1 (en) 2011-06-01 2012-12-06 Estetra S.A. Process for the production of estetrol intermediates
RS54880B1 (sr) 2011-06-01 2016-10-31 Estetra Sprl Postupak proizvodnje intermedijarnih proizvoda estetrola
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
US9579329B2 (en) * 2011-08-11 2017-02-28 Estetra S.P.R.L. Use of estetrol as emergency contraceptive
HK1207588A1 (en) 2012-11-22 2016-02-05 Bayer Pharma Aktiengesellschaft Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception
WO2014187744A1 (de) 2013-05-23 2014-11-27 Bayer Pharma Aktiengesellschaft Pharmazeutische zusammensetzung und deren verwendung sowie anwendungsregime dieser pharmazeutischen zusammensetzung zur bedarfsweisen („on-demand") kontrazeption
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
CN107810001A (zh) 2015-06-18 2018-03-16 密特拉制药公司 含雌四醇的口腔分散片剂
CA2988362C (en) 2015-06-18 2022-07-19 Mithra Pharmaceuticals S.A. Orodispersible tablet containing estetrol
CN107787224A (zh) 2015-06-18 2018-03-09 密特拉制药公司 含雌四醇组分的口腔分散剂量单位
PL3106148T3 (pl) 2015-06-18 2018-08-31 Mithra Pharmaceuticals S A Jednostka dawkowania ulegająca rozpadowi w jamie ustnej zawierająca składnik estetrolowy
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
US20230338355A1 (en) * 2020-07-30 2023-10-26 Acer Therapeutics Inc. Nk antagonists for contraception
CN119523923A (zh) * 2024-11-21 2025-02-28 华中药业股份有限公司 一种左炔诺孕酮片及其制备方法

Also Published As

Publication number Publication date
AP1849A (en) 2008-05-23
MXPA04005104A (es) 2004-08-19
PT1448207E (pt) 2005-08-31
GEP20063882B (en) 2006-07-25
KR100908161B1 (ko) 2009-07-16
EP1448207B1 (en) 2005-04-27
HUP0105173A3 (en) 2004-03-29
WO2003045397A1 (en) 2003-06-05
RS4204A (sr) 2007-02-05
ZA200404114B (en) 2005-10-26
BR0210595A (pt) 2004-06-08
OA12730A (fr) 2006-06-28
HRP20040584B1 (en) 2012-11-30
NO333984B1 (no) 2013-11-04
IL159394A0 (en) 2004-06-01
HUP0105173A2 (hu) 2003-08-28
UA79942C2 (en) 2007-08-10
JP2005516904A (ja) 2005-06-09
EA006545B1 (ru) 2006-02-24
ES2239727T3 (es) 2005-10-01
HUP0105173D0 (en) 2002-02-28
AU2002347401A1 (en) 2003-06-10
ATE293978T1 (de) 2005-05-15
MA27076A1 (fr) 2004-12-20
PL369520A1 (en) 2005-04-18
AP2004003046A0 (en) 2004-06-30
CA2450359C (en) 2011-05-10
CN1551774A (zh) 2004-12-01
NZ530056A (en) 2005-02-25
HRP20040584A2 (en) 2005-02-28
HU227198B1 (en) 2010-10-28
KR20040066088A (ko) 2004-07-23
SI1448207T1 (en) 2005-10-31
DE60203929D1 (de) 2005-06-02
DK1448207T3 (da) 2005-06-27
TNSN04048A1 (en) 2006-06-01
US20050288264A2 (en) 2005-12-29
EP1448207A1 (en) 2004-08-25
IS7065A (is) 2003-12-05
NO20041607L (no) 2004-04-20
ECSP045171A (es) 2004-08-27
RS50768B (sr) 2010-08-31
CA2450359A1 (en) 2003-06-05
US20050032755A1 (en) 2005-02-10
DE60203929T2 (de) 2006-01-19
EA200400731A1 (ru) 2004-12-30
PL206010B1 (pl) 2010-06-30

Similar Documents

Publication Publication Date Title
IS2691B (is) Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð
CY2021020I2 (el) Συστημα παραδοσης φαρμακων που αποτελειται απο τετραϋδροξυλιοποιημενο οιστρογονο για χρηση στην ορμονικη αντισυλληψη
DE60202110D1 (de) Notrufsystem und Vorrichtung
IS7076A (is) Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni
ATE447972T1 (de) Darreichungsform zur hormonalen kontrazeption
NO20034620L (no) Pustemaske
IS2821B (is) Amínóalkýlbensóýl-bensófúran eða bensóþíófenafleiður, aðferð til framleiðslu þeirra og samsetningar sem innihalda þær
DK1322158T3 (da) Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
AU2003269434A8 (en) Emergency escape mask
NO20033120D0 (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
NO20023841D0 (no) Anvendelse av glukokortikoidreseptorantagonister for forebygging og behandling av sykdommer av reproduksjonssystemethos menn
EP1404806A4 (en) PREVENTIVE MAN
DK1404663T3 (da) Eurotinoner og derivater deraf, fremgangsmåde til deres fremstilling og anvendelse heraf
EP1413314A4 (en) MEDICAL COMPOSITIONS
DK1406591T3 (da) Farmaceutisk sammensætning til nasal tilförsel af estradiol og norethisteron
SE0102824D0 (sv) Preventivmedel
DK1337528T3 (da) Benzothiophenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
AU2002344537A1 (en) Breathing mask device and application device and frontal support device thereof
HU0100027V0 (en) Contraceptive device
DK1263727T3 (da) 2-oxo-1-pyrrolidinderivater, fremgangsmåder til fremstilling deraf og anvendelser deraf
TW554750U (en) Structure of C-shaped mask forming device
GB0113683D0 (en) Therapeutic mask
SE0101566D0 (sv) Bettskena
SE0100607D0 (sv) Breathing mask